This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Baden-Württemberg Stiftung Gmbh, Helmholtz Zentrum Muenchen, Universitaet Zu Koeln. Active years: 2020-2026.
Company Filing History:
1 out of 2 
1 out of 1 
1 out of 16 Years Active: 2020-2026
Title: Karl Kenji Schorpp: Innovator in Cancer Therapeutics
Introduction
Karl Kenji Schorpp is a notable inventor based in Munich, Germany. He has made significant contributions to the field of cancer therapeutics through his innovative research and development.
Latest Patents
Schorpp holds a patent for a CPAP-tubulin module. This invention relates to CPAP-tubulin inhibitors characterized by a general formula and their use as cancer therapeutics. His work in this area has the potential to impact cancer treatment significantly.
Career Highlights
Throughout his career, Schorpp has worked with esteemed institutions such as the University of Cologne and Helmholtz Zentrum München. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Schorpp has collaborated with notable colleagues, including Kamyar Hadian and Michael Sattler. These partnerships have fostered a productive environment for innovation and research.
Conclusion
Karl Kenji Schorpp's contributions to cancer therapeutics through his patent and collaborations highlight his role as an influential inventor in the field. His work continues to inspire advancements in medical research and treatment options.